BPC-157 for sale is offered strictly for research and educational purposes only
It is not approved for human or veterinary use and is not intended for clinical administration, therapeutic treatment, or diagnostic procedures
Beginning in July 2014, after giving his informed consent, the patient underwent the following treatment: Combined therapy with oral antioxidants propolis 600 mg + bilberry 160 mg + silymarin 400 mg + ginkgo biloba 250 mg + L-carnitine 1000 mg + coenzyme Q10 100 mg + Boswellia 200 mg + vitamin E 30 mg/daily/ + opical diclofenac gel 4%/2 daily for 12 months
The brain was dissected and extracted from the skull and immersed in oxygenated perfusion solution
It works systemically, not locally: Unlike BPC-157, which targets a specific injury site, TB-500 travels through the entire body and finds damaged tissue wherever it is, making it effective for diffuse or multi-site injuries